SRPT - Sarepta Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 56.09B
Enterprise Value 35.68B
Trailing P/E N/A
Forward P/E 1-16.48
PEG Ratio (5 yr expected) 156.75
Price/Sales (ttm)17.67
Price/Book (mrq)5.54
Enterprise Value/Revenue 316.47
Enterprise Value/EBITDA 6-15.64

Trading Information

Stock Price History

Beta (3Y Monthly) 1.92
52-Week Change 3-44.73%
S&P500 52-Week Change 33.49%
52 Week High 3165.87
52 Week Low 381.33
50-Day Moving Average 3109.48
200-Day Moving Average 3123.75

Share Statistics

Avg Vol (3 month) 31.71M
Avg Vol (10 day) 31.4M
Shares Outstanding 574.34M
Float 70.43M
% Held by Insiders 15.25%
% Held by Institutions 192.55%
Shares Short (Aug 15, 2019) 413.59M
Short Ratio (Aug 15, 2019) 410.89
Short % of Float (Aug 15, 2019) 422.78%
Short % of Shares Outstanding (Aug 15, 2019) 418.28%
Shares Short (prior month Jul 15, 2019) 412.87M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Jul 12, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -165.52%
Operating Margin (ttm)-111.46%

Management Effectiveness

Return on Assets (ttm)-16.03%
Return on Equity (ttm)-63.43%

Income Statement

Revenue (ttm)344.58M
Revenue Per Share (ttm)4.91
Quarterly Revenue Growth (yoy)28.70%
Gross Profit (ttm)-131.1M
EBITDA -362.89M
Net Income Avi to Common (ttm)-570.33M
Diluted EPS (ttm)-8.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.12B
Total Cash Per Share (mrq)15.11
Total Debt (mrq)488.41M
Total Debt/Equity (mrq)44.43
Current Ratio (mrq)8.81
Book Value Per Share (mrq)14.79

Cash Flow Statement

Operating Cash Flow (ttm)-460.98M
Levered Free Cash Flow (ttm)-309.89M